Contact | Investor Relations
Jun 02, 2022
Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S.
Evonik, one of the world's leading providers of drug delivery technologies, is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. ... MORE